Sign inGet started

Spada Alfred P.

Insider CIK 1580465 · CNAT See Remarks

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
HSTO Histogen Inc. A Award deriv2023-02-232023-02-27106,793— $0106,793SEC↗
HSTO Histogen Inc. M Exercise deriv2020-05-222020-05-2731,343— $00SEC↗
HSTO Histogen Inc. F Tax w/h2020-05-222020-05-2712,960$0.56 $7.3K19,595SEC↗
HSTO Histogen Inc. M Exercise2020-05-222020-05-2731,343— $032,555SEC↗
CNAT Conatus Pharmaceuticals In D To issuer deriv2019-08-012019-08-01100,000— $00SEC↗
CNAT Conatus Pharmaceuticals In D To issuer deriv2019-08-012019-08-0150,000— $00SEC↗
CNAT Conatus Pharmaceuticals In D To issuer deriv2019-08-012019-08-01109,375— $00SEC↗
CNAT Conatus Pharmaceuticals In D To issuer deriv2019-08-012019-08-0121,875— $00SEC↗
CNAT Conatus Pharmaceuticals In D To issuer deriv2019-08-012019-08-01100,625— $00SEC↗
CNAT Conatus Pharmaceuticals In D To issuer deriv2019-08-012019-08-0170,000— $00SEC↗
CNAT Conatus Pharmaceuticals In D To issuer deriv2019-08-012019-08-01175,000— $00SEC↗
CNAT Conatus Pharmaceuticals In A Award deriv2019-08-012019-08-01313,436— $0313,436SEC↗
CNAT Conatus Pharmaceuticals In A Award deriv2019-02-072019-02-11175,000— $0175,000SEC↗
CNAT Conatus Pharmaceuticals In M Exercise deriv2018-02-272018-03-0112,121— $00SEC↗
CNAT Conatus Pharmaceuticals In M Exercise2018-02-272018-03-0112,121$1.24 $15.0K12,121SEC↗
CNAT Conatus Pharmaceuticals In A Award deriv2018-02-042018-02-0570,000— $070,000SEC↗
CNAT Conatus Pharmaceuticals In A Award deriv2017-01-262017-02-01100,625— $0100,625SEC↗
CNAT Conatus Pharmaceuticals In A Award deriv2016-02-042016-02-0821,875— $021,875SEC↗
CNAT Conatus Pharmaceuticals In A Award deriv2016-02-042016-02-08109,375— $0109,375SEC↗
CNAT Conatus Pharmaceuticals In A Award deriv2015-02-232015-02-25100,000— $0100,000SEC↗
CNAT Conatus Pharmaceuticals In A Award deriv2014-02-072014-02-1150,000— $050,000SEC↗
CNAT Conatus Pharmaceuticals In C Conversion deriv2013-07-302013-08-01363,927— $00SEC↗
CNAT Conatus Pharmaceuticals In C Conversion2013-07-302013-08-0144,112— $0235,021SEC↗